| V-CO-INVESTORS-3-LLC |
V-CO-INVESTORS-3-LLC |
90%
|
Pursuant to the PIPE SPA, the Company sold to V-Co 3 in a private placement offering |
| NEW-SENECA-PARTNERS-INC |
NEW-SENECA-PARTNERS-INC |
85%
|
V-Co 3 is an affiliate of New Seneca Partners Inc., a Michigan corporation |
| ADVANCED-FACIALDONTICS-LLC |
ADVANCED-FACIALDONTICS-LLC |
62%
|
ional profit center for both Vivos and providers. ○ Vivos Vida™ is our proprietary FDA-cleared appliance (unspecified classification) that incorporates our patented Unilateral Biteblock technology fo… |
| AIRWAY-INTEGRATED-MANAGEMENT-COMPANY-LLC |
AIRWAY-INTEGRATED-MANAGEMENT-COMPANY-LLC |
62%
|
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo… |
| AIRWAY-INTELLIGENCE-CENTER-LLC |
AIRWAY-INTELLIGENCE-CENTER-LLC |
62%
|
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo… |
| BIOMODELING-SOLUTIONS-INC |
BIOMODELING-SOLUTIONS-INC |
62%
|
sible that other federal, state or foreign enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitut… |
| CORRECTIVE-BIOTECHNOLOGIES-INC |
CORRECTIVE-BIOTECHNOLOGIES-INC |
62%
|
C. Notes to the Consolidated Financial Statements NOTE 1 - ORGANIZATION, DESCRIPTION AND SIGNIFICANT ACCOUNTING POLICIES Organization BioModeling Solutions, Inc. (“BioModeling”) was organized on Marc… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
y known as “activist investors”) seek to increase short-term stockholder value by advocating corporate actions such as financial restructuring, increased borrowing, special dividends, stock repurchas… |
| DETROIT-LLC |
DETROIT-LLC |
62%
|
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo… |
| FIRST-VIVOS-INC |
FIRST-VIVOS-INC |
62%
|
C. Notes to the Consolidated Financial Statements NOTE 1 - ORGANIZATION, DESCRIPTION AND SIGNIFICANT ACCOUNTING POLICIES Organization BioModeling Solutions, Inc. (“BioModeling”) was organized on Marc… |
| M-A-GROUP |
M-A-GROUP |
62%
|
. Under our new model, we generate revenue through (i) sleep testing services and (ii) via our SAMC facilities, patient customized OSA treatments (which can include, but are not limited to, treatment… |
| MISLEEP-SOLUTION-LLC |
MISLEEP-SOLUTION-LLC |
62%
|
lly generate collections in excess of $500,000 per month, net of adjustments, with contribution margins above 50%. In addition to current Vivos diagnostic and treatment options, we expect to be able … |
| MYCARDIO-LLC |
MYCARDIO-LLC |
62%
|
. Under our new model, we generate revenue through (i) sleep testing services and (ii) via our SAMC facilities, patient customized OSA treatments (which can include, but are not limited to, treatment… |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
leared mRNA appliance ® (collectively with special proprietary treatment modalities that comprises The Vivos Method), and (2) First Vivos, Inc., a Texas corporation (“ First Vivos ”), which proposed … |
| REGAL-CAPITAL-VENTURE-PARTNERS-LLC |
REGAL-CAPITAL-VENTURE-PARTNERS-LLC |
62%
|
resenting of a claim to the government knowing such claim to be false, fictitious or fraudulent and, unlike the federal civil False Claims Act, requires proof of intent to submit a false claim. When … |
| V-CO-INVESTORS-LLC |
V-CO-INVESTORS-LLC |
62%
|
leared mRNA appliance ® (collectively with special proprietary treatment modalities that comprises The Vivos Method), and (2) First Vivos, Inc., a Texas corporation (“ First Vivos ”), which proposed … |
| VIVOS-AIRWAY-ALLIANCE-LLC |
VIVOS-AIRWAY-ALLIANCE-LLC |
62%
|
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo… |
| VIVOS-BIOTECHNOLOGIES-INC |
VIVOS-BIOTECHNOLOGIES-INC |
62%
|
resenting of a claim to the government knowing such claim to be false, fictitious or fraudulent and, unlike the federal civil False Claims Act, requires proof of intent to submit a false claim. When … |
| VIVOS-PROVIDERS-NETWORK-LLC |
VIVOS-PROVIDERS-NETWORK-LLC |
62%
|
2024, we entered into our first contractual alliance with Rebis Health, a sleep center operator in Colorado. Revenues from this arrangement have not developed as we had expected for many reasons beyo… |
| WESTERN-COPERNICUS-GROUP |
WESTERN-COPERNICUS-GROUP |
62%
|
ida Sleep™ is an FDA 510(k) cleared Class II for treating mild to moderate OSA in adults. ● Vivos Versa™ is an FDA 510(k) cleared Class II device for treating mild to moderate OSA in adults. All of t… |
| WIRB-COPERNICUS-GROUP-INC |
WIRB-COPERNICUS-GROUP-INC |
62%
|
ida Sleep™ is an FDA 510(k) cleared Class II for treating mild to moderate OSA in adults. ● Vivos Versa™ is an FDA 510(k) cleared Class II device for treating mild to moderate OSA in adults. All of t… |
| WYOMING-BUSINESS-CORPORATION |
WYOMING-BUSINESS-CORPORATION |
62%
|
leared mRNA appliance ® (collectively with special proprietary treatment modalities that comprises The Vivos Method), and (2) First Vivos, Inc., a Texas corporation (“ First Vivos ”), which proposed … |
